Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina

Circulation

Volumn 105, Issue 20, 2002, Pages 2367-2372

  De Feyter, P J ^a   Serruys, P W ^a   Unger, F ^b   Beyar, R ^c   De Valk, V ^d   Milo, S ^c   Simon, R ^e   Regensburger, D ^f   Crean, P A ^g   McGovern, E ^g   Van Den Heuvel, P ^h   Van Cauwelaert, C ^h   Penn, I ⁱ   Tyers, G F O ⁱ   Lindeboom, W ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Salzburger Landeskliniken   (Austria)

^c RAMBAM MEDICAL CENTER   (Israel)

^d CARDIALYSIS   (Netherlands)

^e UNIVERSITY OF KIEL   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g ST JAMES S HOSPITAL   (Ireland)

^h Academic Hospital Middelheim   (Belgium)

ⁱ VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Angioplasty; Revascularization; Stents; Surgery

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BYPASS SURGERY; CEREBROVASCULAR DISEASE; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DEATH; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS;

EID: 0037150161     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000016643.34907.17     Document Type: Article

References (32)

1. Determinants of operative mortality and long-term survival in patients with unstable angina: The CASS experience
2. Coronary artery bypass grafting for postinfarction angina pectoris
3. The risk of coronary bypass surgery for patients with postinfarction angina
4. Recent preoperative myocardial infarction increases the risk of surgery for unstable angina
5. Ten-year survival after coronary bypass surgery for unstable angina
6. Assessing the outcomes of coronary artery bypass graft surgery: How many risk factors are enough?
7. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery: The Working Group Panel on the Cooperative CABG Database Project
8. A model that predicts morbidity and mortality after coronary artery bypass graft surgery
9. Early late mortality after surgery for unstable angina in relation to Braunwald class
10. Early and late outcome after CABG in patients with evolving myocardial infarction
11. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: Frequency, prediction, clinical course, management, and follow-up
12. Short- and long-term outcome after PTCA in patients with stable and unstable angina
13. Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina
14. Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris
15. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty: Helvetica Investigators
16. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization: EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications
17. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study
18. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization: The EPILOG Investigators
19. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty: The Restore Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis
20. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoproteinIIb/IIIa blockade: The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting
21. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
22. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status
23. Long-term results of RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting
24. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)
25. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
26. Grading of angina pectoris
27. Unstable angina: A classification
28. Secular trends in Q wave and non-Q wave acute myocardial infarction: The Minnesota Heart Survey
29. Myonecrosis after revascularization procedures
30. Estimation of a common effect parameter from sparse follow-up data
31. Fieller's theorem and a generalization
32. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study